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Rift Valley fever virus (RVFV) is transmitted among susceptible animals by mosquito
vectors. Although the virus can be isolated from nasal and oral swabs of infected
animals and is known to be highly infectious when administered experimentally via oral
or respiratory route, horizontal transmission of the virus is only sporadically reported in
literature. We considered that immunosuppression resulting from stressful conditions in
the field may increase the susceptibility to horizontally transmitted RVFV. Additionally, we
reasoned that horizontal transmission may induce immune responses that could affect
the susceptibility of contact-exposed animals to subsequent infection via mosquito
vectors. To address these two hypotheses, viremic lambs were brought into contact with
sentinel lambs. One group of sentinel lambs was treated with the immunosuppressive
synthetic glucocorticosteroid dexamethasone and monitored for signs of disease and
presence of virus in the blood and target organs. Another group of contact-exposed
sentinel lambs remained untreated for three weeks and was subsequently challenged
with RVFV. We found that none of the dexamethasone-treated contact-exposed lambs
developed detectable viremia, antibody responses or significant increases in cytokine
mRNA levels. Susceptibility of immunocompetent lambs to RVFV infection was not
influenced by previous contact-exposure. Our results are discussed in light of previous
findings.
Keywords: Rift Valley fever virus, transmission, epidemiology, risk assessment, contact-exposure, horizontal
transmission
INTRODUCTION
Rift Valley fever virus (RVFV) causes considerable morbidity and mortality among domesticated
ruminants and occasionally humans. RVF outbreaks are generally preceded by massive expansions
of mosquito populations, triggered by periods of heavy rainfall. RVFV has a very broad host range,
but domesticated ruminants play a key role in the epidemiology of the disease by developing
sufficiently high viremia to allow transmission to susceptible mosquitoes. The virus is currently
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confined to the African continent, the Arabian Peninsula and
several islands off the coast of Southern Africa but continues to
expand its habitat. Future incursions into previously unaffected
areas could have dramatic consequences as mosquito species
associated with transmission of the virus in endemic areas are
globally prevalent (Bird et al., 2009; Pepin et al., 2010).
The earliest and perhaps most elegant studies on RVFV
transmission were performed by Daubney and Hudson, who
first characterized and named the disease (Daubney et al.,
1931). Subsequent studies by Findlay revealed that experimental
infection can be achieved by intramuscular, intravenous,
subcutaneous, intraperitoneal, intracerebral, intranasal, or
conjunctival inoculation (Findlay, 1932). Importantly, inhalation
of virus-containing aerosols was also found to result in infection
(Brown et al., 1981; Reed et al., 2013; Hartman et al., 2014).
Whereas experimental infection via artificial inoculation
routes yielded consistent results, those obtained from studies
on natural exposure routes, including contact, inhalation, or
ingestion seem inconsistent. Daubney found that contact-
exposed lambs did not develop disease (Daubney et al., 1931),
whereas Weiss reported that RVFV was able to spread from
infected mice to suckling mice via handling (Weiss, 1957).
In one study, mice and rats did not become infected after
being fed livers and spleens from infected animals (Findlay,
1932), whereas others reported transmission among mice via
cannibalism (Mims, 1956). Easterday et al. (1962) successfully
infected lambs by swabbing the buccal mucosa, demonstrating
that lambs can be infected with RVFV via oral route. They
also found that mice, hamsters, non-human primates, and lambs
can be infected via respiratory route (Easterday et al., 1962;
Easterday, 1965). In more recent studies involving mice and non-
human primates, efficient infection via the respiratory route was
confirmed (Reed et al., 2013; Hartman et al., 2014). Several studies
reported isolation of the virus from oral and nasal swabs and
two studies reported horizontal transmission to a single contact-
exposed sheep (Harrington et al., 1980; Busquets et al., 2010). The
combined results of these previous studies suggest that RVFV
can be transmitted horizontally, but also that transmission via
these routes is either very inefficient or rarely results in disease.
Considering that animal trials are generally performed with
animals of optimal physical health, we anticipated that animals
suffering from immunosuppression resulting from co-infections
or stressful conditions in the field might be more susceptible
to horizontally transmitted RVFV. In addition, we considered
that horizontal transmission to immunocompetent animals may
result in local, subclinical infections with associated innate or
adaptive immune responses that could change the susceptibility
to infection via mosquito bite.
In the present work, we investigated the epidemiological
significance of horizontal transmission by co-housing infected
lambs with dexamethasone-treated lambs and by evaluating
the susceptibility of immunocompetent lambs to experimental
RVFV infection following contact exposure. The results suggest
that contact-exposure of lambs does not result in disease,
even when animals are immunocompromised, and that contact
exposure does not significantly affect the susceptibility to
infection.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were conducted in accordance with
the Dutch Law on Animal Experiments (Wod, ID number
BWBR0003081) and approved by the Animal Ethics Committee
of CVI-Lelystad. To minimize suffering of the animals during the
experiment, lambs were humanely euthanized when they could
no longer be stimulated to drink, feed, or stand.
Preparation of the challenge virus
Rift Valley fever virus isolate 35/74 was used as the challenge
virus. The virus was amplified and titrated on baby hamster
kidney (BHK) cells cultured with CO2-independent medium
(CIM, Invitrogen), supplemented with 5% FBS and 1%
penicillin–streptomycin (Invitrogen). Titers were expressed
as tissue culture infective dose 50 (TCID50) according the
Spearman–Kärber algorithm (Spearman, 1908; Kärber, 1931).
The virus was handled under biosafety level-3 laboratory
conditions in class-III biosafety cabinets.
Experiment A
Twenty conventional European breed lambs, between 7 and
9 weeks of age, purchased from a commercial sheep farm
in The Netherlands, were divided over one group of four
animals and two groups of eight animals. Lambs were housed
in biosafety level-3 containment facilities. Groups were color-
coded according to their treatment (Figure 1A). On day 0 lambs
from the red group (four animals) were sedated by intramuscular
administration of 40 µg/kg medetomidine (Sedator R© , Eurovet,
The Netherlands) and subsequently inoculated with 1 ml cell
culture medium containing 105 TCID50 of RVFV strain 35/74
in the vena jugularis using a 18 gauge, 25 mm needle. The
group of four animals was housed indoors for 1 day in a
pen of 8 m2. The next morning, these inoculated lambs were
brought into contact with eight sentinel lambs (orange group,
Figure 1A). From this point onward, the lambs were held
in a pen of 12 m2. From day 0 until day 10, the sentinel
lambs were treated daily, via intramuscular injection, with 1 ml
of 2 mg/ml dexamethasone (Pro Inj, Alfasan, Woerden, The
Netherlands). A group of eight separately housed control lambs
was treated with dexamethasone only (blue lambs, Figure 1A).
Lambs were subsequently monitored for 14 days and EDTA
blood samples for detection of viremia were collected daily up
to day 12. Serum samples for analyses of antibody responses
were collected weekly. To prevent possible predisposition to
horizontal transmission by damaging mucosal tissues, no rectal
or oral swabs were collected. At the end of the experiment
(day 14) surviving lambs were euthanized by intravenous
administration of 50 mg/kg sodium pentobarbital (Euthasol R© ,
ASTfarma, The Netherlands) and subsequent exsanguination.
Upon necropsy of contact and control animals, liver, spleen,
lung and tonsils samples were collected. To prevent the
risk of transmission of RVFV via aerosols, no necropsy was
performed on lambs from the red group that succumbed to the
infection.
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FIGURE 1 | Dexamethasone-treated lambs do not show any evidence of infection upon contact with RVFV viremic lambs. (A) Cartoon representing the
experimental design. Four lambs (red) were inoculated with RVFV via intravenous route and co-housed with eight dexamethasone-treated lambs (orange) the next
day until the end of the experiment. Another group of 8 lambs functioned as a control group (blue). Rectal temperatures (B), viremia (C), antibody responses by
ELISA (D), and virus neutralization test (VNT) (E) and % survival (F) are depicted. Error bars represent averages with SD.
Experiment B
Experiment B was performed in parallel with experiment A,
with another 20 lambs of the same age and supplier. Lambs
were housed in pens as described above. These lambs were
also divided over three groups consisting of one group of 4
(red group, Figure 2A) and two groups of 8 lambs (orange
and blue, Figure 2A). The red group was treated similar as the
red group of experiment A. The orange (contact-exposed) and
blue (control) groups did not received dexamethasone treatment
but were challenged with wild-type virus (1 ml, 105 TCID50,
strain 35/74) three weeks after contact exposure. Starting on
day 21, EDTA blood samples for the detection of viremia
and PAXgene blood samples (PreAnalytiX) for the analyses of
cytokine responses, were collected daily. Serum samples for the
detection of antibodies were collected weekly.
Diagnostic Procedures
Detection of viral RNA was performed by quantitative real-time
PCR (qRT-PCR) as described (Kortekaas et al., 2012). Briefly,
RNA was isolated from plasma samples using the RNAeasy
kit (Qiagen). Primers, probes and cycling conditions on the
LightCycler were used as described previously (Kortekaas et al.,
2012). Virus isolations from plasma samples were performed by
incubation of 1:1 diluted samples with BHK cells. Inocula were
replaced after 1.5 h incubation, and replaced with fresh culture
medium. Five days post inoculation, cytopathic effect was scored.
Tissue homogenates for qRT-PCR analysis and virus isolation
were prepared as described previously with some modifications
(Kortekaas et al., 2012). Briefly, tissue homogenates for virus
isolation were prepared by homogenizing approximately 1.5 g
of tissue in a IKA R© Ultra Turrax tube DT20 (IKA) in 15 ml
CO2-independent medium (Gibco). Cell debris was subsequently
removed by slow-speed centrifugation and 200 µl was used for
RNA isolation as described for the plasma samples. Cleared
lysates (0.75 ml) were also directly added to BHK cells to achieve
optimal sensitivity of virus isolation, in six well plates, and
incubated for 2 h at RT. After replacement by fresh medium, the
plates were incubated for 6 days at 37◦C.
The commercial IDScreen R© Rift Valley Fever Competition
ELISA (ID-VET, Montpellier,France) was used to detect
antibodies against the RVFV N protein.
Virus neutralizing antibodies were detected using a recently
developed highly sensitive virus neutralization test (VNT), which
makes use of a 4-segmented RVFV expressing enhanced GFP
(Wichgers Schreur et al., 2014, 2015). Briefly, ∼200 TCID50 of
the RVFV-LMMSeGFP virus was incubated with threefold serial
Frontiers in Microbiology | www.frontiersin.org 3 March 2016 | Volume 7 | Article 287
fmicb-07-00287 March 3, 2016 Time: 19:44 # 4
Wichgers Schreur et al. Horizontal Transmission of RVFV
FIGURE 2 | Contact-exposure with viremic lambs does not affect the susceptibility to infection of healthy contact lambs. (A) Cartoon representing the
experimental design. Four lambs (red) were inoculated on day 0 (D0) with RVFV via intravenous route and co-housed with eight untreated lambs (orange) the next
day. One lamb died from unrelated illness and was removed from the study. A group of eight lambs functioned as a control group (blue). On D21 contact-exposed
lambs (orange) and control lambs (blue) were experimentally infected. Rectal temperatures (B), viremia (C), antibody responses by ELISA (D) and VNT (E) and %
survival (F) are depicted. Error bars represent averages with SD. (G) displays viral RNA copies of each individual lamb of the orange group as determined from day
20, of which the average viral RNA levels are displayed in (C). Measurements of samples of lamb 8836 are connected by a dashed line.
dilutions of sera in 96-well plates. After a 2-h incubation period,
40,000 BHK cells were added per well. After 2 days incubation
at 37◦C and 5% CO2, eGFP expression was evaluated with
an EVOS-FL microscope. VNT titers were calculated using the
Spearman–Kärber algorithm.
Cytokine mRNA Levels
RNA was isolated from peripheral blood mononuclear cells
(PBMC) collected in PAXgene Blood RNA Tubes (PreAnalytiX).
Briefly, PBMCs were pelleted and washed according the PAXgene
protocol and lysed in 300 µl Trizol-LS (Invitrogen). Total
RNA was subsequently extracted using the Direct-zolTM RNA
MiniPrep kit (Zymo research) according the manufacturers’
instructions. 50–200 ng RNA of each sample was subsequently
reverse-transcribed using Oligo-Dt and Superscript III reverse
transcriptase (Promega). SYBR green based qRT-PCRs of IL-8,
IL-1β, IL-6, IL-10, TNF, and IFN-γ were performed as described
previously (Wichgers Schreur et al., 2011). Primer sequences
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are listed in Supplemental Table 1. Gene expression levels were
normalized with the house keeping gene gapdh. To determine
gene-expression kinetics, fold-inductions compared to day 0 were
calculated.
Histopathology and
Immunohistochemistry
Tissues for histopathology were fixed in 10% phosphate-buffered
formalin for a minimum of 48 h and processed into paraffin.
Sections of 4 µm were placed on silane-coated glass slides
and dried for at least 48 h at 37◦C. After deparaffinization
and rehydration in graded alcohols, endogenous peroxidase
activity was blocked in methanol/H2O2. Sections were pre-
treated by 15 min autoclaving at 121◦C in citrate buffer
(pH 6.0). After cooling down, sections were incubated for
60 min with the monoclonal antibody 4-D4, which is directed
against the Gn protein of RVFV (kindly provided by Dr.
Connie Schmaljohn, USAMRIID). Mouse Envision horseradish
peroxidase (Dakopatts, Denmark) was used as the secondary
antibody and diaminobenzidine as the substrate.
RESULTS
Contact Exposure of
Dexamethasone-Treated Lambs
(Experiment A)
To study if exposure to viremic lambs results in disease
in immunocompromised lambs, 4 lambs were experimentally
infected with RVFV via the intravenous route (Figure 1A, red
group) and brought into contact with eight dexamethasone-
treated sentinel lambs (Figure 1A, orange group) the day after
inoculation. The lambs we co-housed for a period of 2 weeks.
A control dexamethasone-treated group, consisting of another
eight lambs was housed separately and was not brought into
contact with RVFV-infected lambs (Figure 1A, blue group).
The four inoculated lambs developed high fever (>41◦C) which
started on the day after challenge and lasted for several days
(Figure 1B). Fever was associated with viremia as determined
by qRT-PCR (Figure 1C). Earlier experiments with lambs have
demonstrated that virus can be isolated from samples that
contain viral RNA levels >105 copies/ml as determined by the
qRT-PCR employed in the present work (Kortekaas et al., 2012).
In line with these earlier results, virus was isolated from all
plasma samples with viral RNA levels >105 copies/ml (data not
shown). One lamb succumbed to the infection on day 4 and
one on day 12 (Figure 1F). None of the dexamethasone-treated
lambs developed fever (>40.5◦C) or viremia, and none of these
lambs developed any sign of disease that could be associated
with horizontally transmitted RVFV. Although RVFV-specific
antibodies were detected by ELISA and VNT in the sera of
the two surviving lambs of Group 1A (Figures 1D,E), none
of the dexamethasone-treated lambs developed RVFV-specific
antibodies. After day 14, all surviving lambs were euthanized and
samples of the liver, spleen, lung and tonsils were collected. From
the organ samples collected from the two lambs of the red group
that recovered from disease, virus was isolated from tonsils. In
addition, virus was isolated from the spleen of one lamb (data
not shown). In the samples collected from the contact-exposed,
dexamethasone-treated lambs, neither infectious virus nor viral
RNA were detected.
Contact Exposure and Subsequent
Challenge Infection of Lambs
(Experiment B)
As an additional hypothesis, we considered the possibility that
horizontally transmitted RVFV to immunocompetent animals
changes the susceptibility to mosquito mediated infection. To
test this hypothesis, a group of four lambs was infected via
the intravenous route (Figure 2A, red group) and brought into
contact with eight healthy lambs (Figure 2A, orange group). The
lambs we co-housed for a period of three weeks. Another group
of eight lambs, housed separately, functioned as a control group
(Figure 2A, blue group). All four experimentally infected lambs
displayed fever associated with viremia by day 2 (Figure 2B). One
lamb died on day 3 and one on day 8 (Figure 2F). Apart from
the lamb that died on day 3, antibodies were detected by both
ELISA and VNT in the remaining three lambs (Figures 2D,E).
No clinical signs were observed in contact-exposed lambs and
no viral RNA or RVFV-specific antibodies were detected in these
animals until day 21 (Figure 2). Of note, one of the contact-
exposed lambs died on day 17 from peritonitis resulting from
purulent omphalophlebitis and was removed from the study.
On day 21, contact-exposed lambs and control lambs were
inoculated with RVFV. All lambs from both groups developed
fever (Figure 2B) and viremia (Figure 2C) within two days
after inoculation. All surviving lambs developed antibodies as
determined by ELISA (Figure 2D) and VNT (Figure 2E). The
percentage of mortality among experimentally infected lambs
was 25% (Figure 2F), which is in line with results from several
previous studies with lambs of 11–13 weeks of age. Remarkably,
mortality in challenged, contact-exposed lambs was 71%, which is
exceptionally high. This high percentage of fatality was associated
with a higher average level of viremia and prolonged fever in
all lambs, although the differences between the groups were
not statistically significant. RVFV RNA levels in liver, spleen,
adrenal gland, lung, retropharyngeal lymph nodes, portal lymph
nodes, and tonsil samples of these animals were also very high
(Figures 3A,B). Similar as previously observed, the majority of
animals that died shortly after the challenge with RVFV revealed
an extensive necrosis of the liver with bridging of necrotic
areas between neighboring liver acini. Immunohistochemistry
staining showed a massive presence of RVF antigen within
the degenerating and necrotic hepatocytes (data not shown).
In addition, RVFV antigen was detected in the mononuclear
phagocyte system of the liver (Figure 3C), spleen, and lymph
nodes as reported previously. Interestingly, an unusual pattern
was observed in the immunohistochemistry analysis of lamb with
number 8836. This lamb developed a delayed, but extremely high
viremia, approaching 1011 copies/ml (dashed line in Figure 2G).
Of note, also the titer of infectious virus reached the highest
level in this animal (>6.3 TCID50/ml). Immunohistochemistry
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FIGURE 3 | Detection of viral RNA and viral antigen in organ samples collected from animals of Experiment B. Detection of viral RNA by qRT-PCR in
organ samples collected from contact-exposed and subsequently challenged lambs (orange frame, A) and of infected control lambs (blue frame, B). Lambs that
succumbed to the infection are marked (†). (C–H) Immunohistochemical staining of organ samples collected from lamb 8836. (C) Detail of liver acinus with strong
immunostaining of hepatocytes. Also note the accumulation of RVFV antigen in Kupffer cells (black arrow) and circulating macrophages (white arrow) within the liver
sinusoids. (D–G) Positive staining for RVFV antigen in the endothelial cells of venules and veins in (D) spleen; (E) tonsil; (F) paracortex of the retropharyngeal lymph
node; and (G) medulla of the portal lymph node. Also note the positive staining in the circulating macrophages (black arrow) and littoral cells (white arrow) in the
medullary sinuses of the lymph node. (H) Portal area of the liver. Note the heavy staining for RVFV antigen in the hepatocytes and the absence of staining of the
endothelial layer of the Vena porta (V). B = bile duct. Bar = 100 µm (C,D,H) and 50 µm (E,F,G).
revealed a heavy staining of the endothelial cells lining both
smaller and larger veins in the spleen, tonsil, and lymph nodes
(Figures 3D–G). Remarkably, staining of endothelial cells was
confined to lymphoid organs, as endothelial cells in the liver and
adrenal gland were negative for RVFV antigen (Figure 3H).
Although contact-exposure did not result in disease, viremia
or antibody responses, we anticipated the possibility that
horizontally transmitted virus may induce subclinical infections
and associated innate immune responses. Systemic innate
immune responses were monitored by measuring cytokine
mRNA levels for a period of 10 days. The results show that
experimental RVFV infection results in strong pro-inflammatory
cytokine responses. However, no significant differences in
cytokine mRNA levels between contact-exposed lambs and
control lambs were observed (Figure 4).
DISCUSSION
Rift Valley fever virus causes high viremia in domesticated
ruminants, but is not present in appreciable amounts in
urine, faces, or milk (Daubney et al., 1931; Easterday, 1965).
The virus can, however, be detected by PCR or be isolated
from oral or rectal swabs of infected ruminants (Saber et al.,
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FIGURE 4 | Cytokine mRNA responses in lambs following RVFV infection or contact-exposure. Whole blood samples were collected from lambs
experimentally infected with RVFV (red), contact-exposed lambs (orange) and separately housed, non-exposed control lambs (blue). Blood samples were collected in
PAXgene tubes for a period of 10 days. RNA was isolated from PBMCs and used for reverse-transcription. Results represent SYBR green based qRT-PCRs of IL-8,
IL-1β, IL-6, IL-10, TNF-α, and IFN-γ. Gene expression levels were normalized with the house keeping gene gapdh. To determine gene-expression kinetics,
fold-inductions compared to day 0 were calculated. Error bars represent averages with SEM.
1984; Busquets et al., 2010, 2014) and was also isolated
from pharyngeal or throat washings from humans (Francis
and Magill, 1935; Abdel-Wahab et al., 1978; Imam et al.,
1979). Considering these findings and the high infectivity
of the virus when delivered via oral route or respiratory
route (Hartman et al., 2013; Reed et al., 2013) it seems
contradictory that horizontal transmission rarely occurs in
nature.
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Harrington et al. (1980) were the first to report horizontal
transmission among sheep under experimental conditions. One
of four contact control sheep developed clinical disease and
detectable viremia at 7 days post exposure (Harrington et al.,
1980). The transmission route remained unknown, as the sheep
had not been in contact with ewes that aborted or with sheep
that had detectable virus in their saliva. More recently, Busquets
and co-workers described transmission of the virus from lamb
to lamb, and also in this case, the transmission route remained
unclear (Busquets et al., 2010).
When we designed the present study, we hypothesized
that ruminants may be more susceptible to horizontally
transmitted RVFV during periods of immunosuppression.
Immunosuppression can result from co-infections or from
stressful conditions. Naturally occurring stressful conditions
may lead to increases in endogenous corticosteroids, which are
potent immunosuppressive agents. In the current work, the
effect of increased endogenous corticosteroids was simulated
by treatment with the synthetic glucocorticosteroidsteroid
dexamethasone, which was previously successfully used in
sheep to re-activate bovine herpesvirus type-5 (Silva et al.,
1999). Exposure of eight dexamethasone-treated lambs to
four highly viremic lambs, of which two succumbed to the
infection, did not result in signs of disease that could be
attributed to RVFV infection and no viral RNA was detected
or viable virus isolated from plasma samples. Despite optimized
virus isolation procedures, no virus was isolated from liver,
spleen, lung and tonsil samples collected from dexamethasone-
treated contact lambs. From this, we conclude that either
no horizontal transmission occurred in this experiment, or
that horizontal transmission did not result in productive
infection.
As a second hypothesis, we considered the possibility
that horizontally transmitted virus induces an immune
response that could change the susceptibility to infection via
mosquito bite. This possibility was considered, as in previous
vaccination/challenge studies with lambs, we occasionally found
animals that were protected from disease in the apparent
absence of vaccine-induced neutralizing antibodies (unpublished
observations). Apart from low levels of antibodies, this
protection could also be mediated by innate or cellular immune
responses, which we intended to detect indirectly, by measuring
cytokine responses. Considering that no antibody or cytokine
responses were detected in contact-exposed lambs and the
fact that these lambs were equally susceptible to subsequent
challenge infection, we conclude that either no virus was
horizontally transmitted in this experiment, or that horizontal
transmission of RVFV does not result in protective immune
responses.
A striking finding in our study involved one of the contact-
exposed and subsequently challenged lambs. This lamb revealed
signs of infection 1–2 days later than usual and subsequently
developed extremely high viremia approaching 1011 copies/ml
within three days post inoculation (dashed line in Figure 2G).
The lamb succumbed to the infection 3 days after onset of viremia
and was found to have significantly higher viral loads in organs.
Remarkably, this seemingly delayed onset, but subsequently fast
development of viremia, disease and mortality was associated
with detection of viral antigen in endothelial cells of lymphoid
organs. Although this phenomenon may have been caused by
a rare event in the host, the possibility should be considered
that one or several mutations in the RVFV genome were
responsible for this finding. If this is indeed the case, this RVFV
variant might have evolutionary advantage over the remaining
population, considering the unusually high viremia levels that
were detected. Clearly, this intriguing finding warrants further
study.
CONCLUSION
Our results provide no evidence that horizontal transmission
of RVFV occurred in the present experiments. Considering the
previous findings of Harrington et al. (1980) and Busquets et al.
(2010) the possibility must be considered that damage of mucosal
tissues as a result of swabbing could have increased both the
shedding potential of viremic animals as well as the susceptibility
of contact-exposed animals in these former studies. In this light,
it must be considered that co-infections that damage mucosal
surfaces may predispose for horizontal transmission of RVFV in
the field.
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